prolaris scoretm (Myriad Genetics)
90
Structured Review
Myriad Genetics
prolaris scoretm
Prolaris Scoretm, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prolaris+scoretm/prolaris+score/pm26709776-79-44-8
Average 90 stars, based on 1 article reviews
Prolaris Scoretm, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prolaris+scoretm/prolaris+score/pm26709776-79-44-8
Average 90 stars, based on 1 article reviews
prolaris scoretm - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
RNA Expression:Article Title: Next generation biomarkers in prostate cancer. Article Snippet: A wide spectrum of non-protein based biomarkers are under development that promises to revolutionize the care of prostate cancer (CaP) patients.. In the context of CaP detection we highlight the potential value of the urine tests PCA3 and ProstarixTM, especially for their ability to stratify patient risk with previous negative biopsy for occult cancer.. The search for such markers is made more complex by the development of MRI and image-fusion technology that can help focus biopsy on specific prostatic lesions. Formalin-fixed Paraffin-Embedded:Article Title: Next generation biomarkers in prostate cancer. Article Snippet: A wide spectrum of non-protein based biomarkers are under development that promises to revolutionize the care of prostate cancer (CaP) patients.. In the context of CaP detection we highlight the potential value of the urine tests PCA3 and ProstarixTM, especially for their ability to stratify patient risk with previous negative biopsy for occult cancer.. The search for such markers is made more complex by the development of MRI and image-fusion technology that can help focus biopsy on specific prostatic lesions. Biomarker Discovery:Article Title: Next generation biomarkers in prostate cancer. Article Snippet: A wide spectrum of non-protein based biomarkers are under development that promises to revolutionize the care of prostate cancer (CaP) patients.. In the context of CaP detection we highlight the potential value of the urine tests PCA3 and ProstarixTM, especially for their ability to stratify patient risk with previous negative biopsy for occult cancer.. The search for such markers is made more complex by the development of MRI and image-fusion technology that can help focus biopsy on specific prostatic lesions. |